The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Atrasentan in Patients With IgA Nephropathy (ALIGN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04573478
Recruitment Status : Active, not recruiting
First Posted : October 5, 2020
Last Update Posted : May 3, 2024
Information provided by (Responsible Party):
Chinook Therapeutics, Inc. ( Chinook Therapeutics U.S., Inc. )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : September 7, 2023
Estimated Study Completion Date : December 1, 2026